Previously, the treatment had only been supplied in a single-dose vial that required administration by a health care professional using a winged infusion set. The Food and Drug Administration (FDA) ...
For people living with primary immunodeficiency, immunoglobulin replacement therapy is a cornerstone of treatment. These therapies help replace missing antibodies and lower the risk of serious ...
The TULIP-SC trial evaluated the efficacy and safety of the subcutaneous administration of SAPHNELO compared to placebo in participants with moderately to severely active, autoantibody-positive SLE, ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Rozanolixizumab's EU approval for self-administration methods aims to improve patient autonomy and satisfaction by minimizing clinic visits. The phase 3 MG0020 study confirmed the safety and efficacy ...
Rozanolixizumab self-administration was 100% successful, with patients preferring the manual push method over infusion pumps for its simplicity and cost-effectiveness. The study involved 55 patients, ...
Cabotegravir and rilpivirine (cabenuva), the only complete HIV treatment regimen delivered by injection, could be given by intramuscular injection to the thigh rather than the gluteal muscles, ...
The editorial staff had no role in this post's creation. Let Google know we are your trusted source.Add our editorial as a preferred source in your search results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results